Improving High-Risk Patient Care through Chronic Disease Prevention and Management

Abstract

Get full access to this article

View all access options for this article.

References

J.M.

McWilliams and

A.L.

Schwartz , “Focusing on High-Cost Patients — The Key to Addressing High Costs?” New England Journal of Medicine 376 (2017): 807-809.

J.K.

Cynamon

, “Normative Concerns with High-Risk Pools,” Journal of Law, Medicine & Ethics 46, no. 3 (2018): 766-772.

See McWilliams, supra note 1.

Hwang ,

LaClair ,

Camacho , and

Paz , “Persistent High Utilization in a Privately Insured Population,” The American Journal of Managed Care 21 (2015): 309-316.

See McWilliams, supra note 1.

J.L.

Pringle ,

Boyer ,

M.H.

Conklin ,

J.W.

McCullough and

Aldridge , “The Pennsylvania Project: Pharmacist Intervention Improved Medication Adherence and Reduced Health Care Costs,” Health Affairs 33 (2014): 1444-1452.

Schurrer ,

O'Malley ,

Wilson ,

McCall , and

Jain , “Evaluation of the Diffusion and Impact of the Chronic Care Management (CCM) Services: Final Report, 50131” (November 2, 2017).

M.E.

Porter ,

M.R.

Kramer and

Sesia , “Discovery Limited,” Harvard Business School Case 715-423 (2014): 1-18.